207 related articles for article (PubMed ID: 26475745)
1. Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Gibbons AS; Jeon WJ; Scarr E; Dean B
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26475745
[TBL] [Abstract][Full Text] [Related]
2. Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine.
Dean B; Tawadros N; Seo MS; Jeon WJ; Everall I; Scarr E; Gibbons A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):895-906. PubMed ID: 24495390
[TBL] [Abstract][Full Text] [Related]
3. Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.
Gibbons AS; Scarr E; McLean C; Sundram S; Dean B
J Affect Disord; 2009 Aug; 116(3):184-91. PubMed ID: 19103464
[TBL] [Abstract][Full Text] [Related]
4. Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.
McOmish CE; Pavey G; Gibbons A; Hopper S; Udawela M; Scarr E; Dean B
J Affect Disord; 2016 Jan; 190():241-248. PubMed ID: 26521087
[TBL] [Abstract][Full Text] [Related]
5. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
Zavitsanou K; Katsifis A; Yu Y; Huang XF
Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
[TBL] [Abstract][Full Text] [Related]
6. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
Cannon DM; Carson RE; Nugent AC; Eckelman WC; Kiesewetter DO; Williams J; Rollis D; Drevets M; Gandhi S; Solorio G; Drevets WC
Arch Gen Psychiatry; 2006 Jul; 63(7):741-7. PubMed ID: 16818863
[TBL] [Abstract][Full Text] [Related]
7. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
Bourin M; Prica C
Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
[TBL] [Abstract][Full Text] [Related]
8. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
[TBL] [Abstract][Full Text] [Related]
9. The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders.
Jeon WJ; Gibbons AS; Dean B
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():7-12. PubMed ID: 23962466
[TBL] [Abstract][Full Text] [Related]
10. AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder.
Gibbons AS; Brooks L; Scarr E; Dean B
J Affect Disord; 2012 Feb; 136(3):1232-7. PubMed ID: 22036795
[TBL] [Abstract][Full Text] [Related]
11. The role of NMDA receptors in the pathophysiology and treatment of mood disorders.
Ghasemi M; Phillips C; Trillo L; De Miguel Z; Das D; Salehi A
Neurosci Biobehav Rev; 2014 Nov; 47():336-58. PubMed ID: 25218759
[TBL] [Abstract][Full Text] [Related]
12. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.
Dean B; Gibbons AS; Tawadros N; Brooks L; Everall IP; Scarr E
Mol Psychiatry; 2013 Jul; 18(7):767-73. PubMed ID: 22801413
[TBL] [Abstract][Full Text] [Related]
13. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
Zavitsanou K; Katsifis A; Mattner F; Huang XF
Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
[TBL] [Abstract][Full Text] [Related]
14. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.
Machado-Vieira R; Zanetti MV; Otaduy MC; De Sousa RT; Soeiro-de-Souza MG; Costa AC; Carvalho AF; Leite CC; Busatto GF; Zarate CA; Gattaz WF
J Clin Psychopharmacol; 2017 Feb; 37(1):40-45. PubMed ID: 27902528
[TBL] [Abstract][Full Text] [Related]
15. Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.
Scarr E; McLean C; Dean B
J Neural Transm (Vienna); 2017 Mar; 124(3):273-284. PubMed ID: 27688247
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.
Teaktong T; Piggott MA; Mckeith IG; Perry RH; Ballard CG; Perry EK
Behav Brain Res; 2005 Jun; 161(2):299-305. PubMed ID: 15922057
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.
Odagaki Y; Kinoshita M; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):937-47. PubMed ID: 23748234
[TBL] [Abstract][Full Text] [Related]
19. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
